Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation-Reference-Cited by-同舟云学术

Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation

Published:2024-01 Issue:1 Volume:105 Page:132-149
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Sourris Karly C.,Ding Yi,Maxwell Scott S.,Al-sharea Annas,Kantharidis Phillip,Mohan Muthukumar,Rosado Carlos J.,Penfold Sally A.,Haase Claus,Xu Yangsong,Forbes Josephine M.^ORCID,Crawford Simon,Ramm Georg,Harcourt Brooke E.,Jandeleit-Dahm Karin,Advani Andrew,Murphy Andrew J.,Timmermann Daniel B.,Karihaloo Anil,Knudsen Lotte Bjerre,El-Osta Assam,Drucker Daniel J.,Cooper Mark E.,Coughlan Melinda T.^ORCID

Publisher

Elsevier BV

Subject

Nephrology

Reference84 articles.

1. Pathogenesis, prevention, and treatment of diabetic nephropathy;Cooper;Lancet,1998

2. Global estimates of the prevalence of diabetes for 2010 and 2030;Shaw;Diabetes Res Clin Pract,2010

3. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective;Parving;Kidney Int,2006

4. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease;Thomas;Nat Rev Nephrol,2016

5. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential of Anti-Inflammatory DC Immunotherapy in Improving Proteinuria in Type 2 Diabetes Mellitus;Vaccines;2024-08-27

2. Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care;Diabetologia;2024-08-23

3. Optimizing kidney and cardiovascular protection in an era of multiple effective treatments;Current Opinion in Nephrology & Hypertension;2024-08-14

4. Impact of hyperglycemia on immune cell function: a comprehensive review;Diabetology International;2024-08-12

5. Lipid lowering effects of incretin-based therapies, relevant for cardiovascular benefit?;Current Opinion in Lipidology;2024-07-30